Abstract:Oxidative stress and mitochondrial damage play an important role in the pathology of cardiomyocytes apoptosis. However, the effects of Astragaloside IV(As-IV) on mitochondrial function have not been uncertain. Therefore, we assumed that As-IV inhibits hydrogen peroxide-induced apoptosis in H9c2 cells by attenuating oxidative stress and mitochondrial damage. To investigate the effects and mechanisms of As-IV on hydrogen peroxide-induced apoptosis in H9c2 cells. H9c2 cells were divided into three groups, including normal control group (cultured without intervention), hydrogen peroxidegroup (cultured with 200 μmol/L hydrogen peroxide for 2 hours), As-IV group (cultured with 100 μmol/L As-IV for 1 hour), As-IV with hydrogen peroxide group (pretreated with 100 μmol/L As-IV for 1 hour, then incubated with hydrogen peroxide for 2 hours). FITC/PI and DCFH-DA are stained to examine levels of apoptosis and ROS receptively. Levels of SOD and MDA were measured. Stained with JC-1 probe to observe the change of mitochondrial membrane potential (MMP). Western-blot was detected to analyze the expression of Drp-1. The apoptosis rate of hydrogen peroxide group ((13.22 ± 3.17 vs 40.55 ± 13.74)%, P < 0.05) was significantly higher than that of control group, which was lower in As-IV with hydrogen peroxide group((23.43 ± 4.3 vs 40.55 ± 13.74) %, P < 0.05). 2. The ROS levels were higher in hydrogen peroxide group than control group((73.53 ± 5.33 vs 39.02 ± 7.90) %, P < 0.05), which were significant reduced in As-IV with hydrogen peroxide group((57.6 ± 4.63 vs 73.53 ± 5.33) %, P < 0.05) Meanwhile, the activity of MDA was increased and the activity of SOD was decreased in hydrogen peroxide group compared with that in control group((10.97 ± 0.56 vs 4.85 ± 0.55) nmol/mL, P < 0.05), ((1192.23 ± 341.59 vs 2710.95 ± 274.32)U/L, P < 0.05). Compared with hydrogen peroxide group, As-IV with hydrogen peroxide group significantly decrease the activity of MDA and increase the activity of SOD ((6.58 ± 0.79 vs 10.97 ± 0.56) nmol/mL, P < 0.05), ((1984.66 ± 188.81 vs 1192.23 ± 341.59) U/L, P < 0.05). 3. MMP was lower and the expression of Drp1 was higher in hydrogen peroxide group than that in control group ((0.31 ± 0.01 vs 1.52 ± 0.25) %, P < 0.05), ((0.86 ± 0.003 vs 0.45 ± 0.004) %, P < 0.05). Compared with hydrogen peroxide group, MMP was significantly increased and the expression of Drp1 was downregulated ((0.65 ± 0.38 vs 0.31 ± 0.01) %, P < 0.05), ((0.72 ± 0.005 vs 0.86 ± 0.003) %, P < 0.05). As-IV exerts protective effects on hydrogen peroxide-induced apoptosis by attenuating oxidative stress and mitochondrial damage.

PS-B12-9: ASTRAGALOSIDE IV INHIBITS HYDROGEN PEROXIDE-INDUCED APOPTOSIS IN H9C2 CELLS BY ATTENUATING OXIDATIVE STRESS AND MITOCHONDRIAL DAMAGE

Protection and Underlying Mechanism of Astaxanthin Against Hydrogen Peroxide-Induced Oxidative Stress in PC-3 Cells

Protection of Astragaloside Derivate on Oxidative Stress and Hypertrophy in Cardiomyocytes

Astragaloside Iv Attenuates Hypoxia-Induced Cardiomyocyte Damage in Rats by Upregulating Superoxide Dismutase-1 Levels

Protective Effects of Astragalosides on Apoptosis of Myocardial Cells Induced by Hydrogen Peroxide

Astragaloside IV alleviates ischemia reperfusion-induced apoptosis by inhibiting the activation of key factors in death receptor pathway and mitochondrial pathway

Astragaloside IV Inhibits Doxorubicin-Induced Cardiomyocyte Apoptosis Mediated by Mitochondrial Apoptotic Pathway Via Activating the PI3K/Akt Pathway.

A Single, Acute Astragaloside IV Therapy Protects Cardiomyocyte Through Attenuating Superoxide Anion-Mediated Accumulation of Autophagosomes in Myocardial Ischemia-Reperfusion Injury

Astragaloside Iv Inhibits Oxidative Stress-Inducedmitochondrial Permeability Transition Pore Opening By Inactivating Gsk-3 Beta Via Nitric Oxide In H9c2 Cardiac Cells

Astragaloside IV protects cardiomyocytes against hypoxia injury via HIF-1α and the JAK2/STAT3 pathway

Astragaloside-IV Protects H9C2(2-1) Cardiomyocytes from High Glucose-Induced Injury Via Mir-34A-mediated Autophagy Pathway.

Astragaloside-IV Protects Against Heat-induced Apoptosis by Inhibiting Excessive Activation of Mitochondrial Ca2+ Uniporter

Effects of astragalus polysaccharide on cell injury and mitochondrial pathway apoptosis in the hypoxia reoxygenation of myocardial cells

Astragaloside IV Alleviates Infarction Induced Cardiomyocyte Injury by Improving Mitochondrial Morphology and Function

Astragaloside IV protects cardiomyocytes from hypoxic injury by regulating endoplasmic reticulum stress via eIF2α/CHOP signaling pathway

Astragaloside IV Alleviates Brain Injury Induced by Hypoxia via the Calpain-1 Signaling Pathway

Astragaloside IV alleviates heart failure by regulating SUMO-specific protease 1

Astragaloside IV Inhibits NLRP3 Inflammasome-Mediated Pyroptosis via Activation of Nrf-2/HO-1 Signaling Pathway and Protects against Doxorubicin-Induced Cardiac Dysfunction

Beneficial effects of astragaloside IV against angiotensin II-induced mitochondrial dysfunction in rat vascular smooth muscle cells

Astragaloside IV Protects Against Oxidized Low-Density Lipoprotein (ox-LDL)-Induced Endothelial Cell Injury by Reducing Oxidative Stress and Inflammation

Astragaloside IV intervenes multi-regulatory cell death forms against doxorubicin-induced cardiotoxicity by regulating AMPKα2 pathway